Danielle T. Avery

Danielle T. Avery

Auto-generated profile, based on publicly available information

Danielle T. Avery

Garvan Institute of Medical Research 1 , Darlinghurst, Australia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2021 in Science Immunology
Verified
Journal Article
Closed access
BKBaerbel Keller
Baerbel Keller
VSValentina Strohmeier
Valentina Strohmeier
IHIna Harder
Ina Harder
SUSusanne Unger
Susanne Unger
KPKathryn J. Payne
Kathryn J. Payne
KWKlaus Warnatz
Klaus Warnatz
T cell–derived IFNγ and CD40L/IL-21R signals are crucial for the differentiation of human T-bet high CD21 low B cells.

17 July 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
DADanielle T. Avery
Danielle T. Avery
AKAlisa Kane
Alisa Kane
TNTina Nguyen
Tina Nguyen
ALAnthony Lau
Anthony Lau
ANAkira Nguyen
Akira Nguyen
STStuart G. Tangye
Stuart G. Tangye
Gain-of-function (GOF) mutations in PIK3CD, encoding the p110δ subunit of phosphatidylinositide 3-kinase (PI3K), cause a primary immunodeficiency. Affected individuals display impaired humoral immune responses following infection or immunization. To establish mechanisms underlying these immune defects, we studied a large cohort of patients with PIK3CD GOF mutations and established a novel mouse model using CRISPR/Cas9-mediated gene editing to introduce a common pathogenic mutation in Pik3cd. In both species, hyperactive PI3K severely affected B cell development and differentiation in the bone marrow and the periphery. Furthermore, PI3K GOF B cells exhibited intrinsic defects in class-switch recombination (CSR) due to impaired induction of activation-induced cytidine deaminase (AID) and failure to acquire a plasmablast gene signature and phenotype. Importantly, defects in CSR, AID expression, and Ig secretion were restored by leniolisib, a specific p110δ inhibitor. Our findings reveal key roles for balanced PI3K signaling in B cell development and long-lived humoral immunity and memory and establish the validity of treating affected individuals with p110δ inhibitors.

22 July 2022 in Science Immunology
Verified
Journal Article
Open access
RYRui Yang
Rui Yang
DADanielle T. Avery
Danielle T. Avery
KJKatherine J. L. Jackson
Katherine J. L. Jackson
MOMasato Ogishi
Masato Ogishi
IBIbtihal Benhsaien
Ibtihal Benhsaien
STStuart G. Tangye
Stuart G. Tangye
High-level expression of the transcription factor T-bet characterizes a phenotypically distinct murine B cell population known as “age-associated B cells” (ABCs). T-bet–deficient mice have reduced ABCs and impaired humoral immunity. We describe a patient with inherited T-bet deficiency and largely normal humoral immunity including intact somatic hypermutation, affinity maturation and memory B cell formation in vivo, and B cell differentiation into Ig-producing plasmablasts in vitro. Nevertheless, the patient exhibited skewed class switching to IgG1, IgG4, and IgE, along with reduced IgG2, both in vivo and in vitro. Moreover, T-bet was required for the in vivo and in vitro development of a distinct subset of human B cells characterized by reduced expression of CD21 and the concomitantly high expression of CD19, CD20, CD11c, FCRL5, and T-bet, a phenotype that shares many features with murine ABCs. Mechanistically, human T-bet governed CD21 lo CD11c hi B cell differentiation by controlling the chromatin accessibility of lineage-defining genes in these cells: FAS , IL21R , SEC61B , DUSP4 , DAPP1 , SOX5 , CD79B , and CXCR4 . Thus, human T-bet is largely redundant for long-lived protective humoral immunity but is essential for the development of a distinct subset of human CD11c hi CD21 lo B cells.

16 December 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ALAnthony Lau
Anthony Lau
DADanielle T. Avery
Danielle T. Avery
KJKatherine Jackson
Katherine Jackson
HLHelen Lenthall
Helen Lenthall
SVstefano volpi
stefano volpi
EDElissa K. Deenick
Elissa K. Deenick
Antibody-mediated autoimmune diseases are a major health burden. However, our understanding of how self-reactive B cells escape self-tolerance checkpoints to secrete pathogenic autoantibodies remains incomplete. Here, we demonstrate that patients with monogenic immune dysregulation caused by gain-of-function mutations in PIK3CD, encoding the p110δ catalytic subunit of phosphoinositide 3-kinase (PI3K), have highly penetrant secretion of autoreactive IgM antibodies. In mice with the corresponding heterozygous Pik3cd activating mutation, self-reactive B cells exhibit a cell-autonomous subversion of their response to self-antigen: instead of becoming tolerized and repressed from secreting autoantibody, Pik3cd gain-of-function B cells are activated by self-antigen to form plasmablasts that secrete high titers of germline-encoded IgM autoantibody and hypermutating germinal center B cells. However, within the germinal center, peripheral tolerance was still enforced, and there was selection against B cells with high affinity for self-antigen. These data show that the strength of PI3K signaling is a key regulator of pregerminal center B cell self-tolerance and thus represents a druggable pathway to treat antibody-mediated autoimmunity.

1 November 2019 in Science Immunology
Verified
Journal Article
Open access
PDF file
JLJuan Li
Juan Li
Marco RitelliMarco Ritelli
Marco Ritelli
CMCindy S. Ma
Cindy S. Ma
GRGeetha Rao
Geetha Rao
THTanwir Habib
Tanwir Habib
APAnne Puel
Anne Puel
Human JNK1 is essential for IL-17A/F–dependent mucocutaneous immunity to Candida and for TGF-β–dependent homeostasis of connective tissues.

21 March 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
TNTina Nguyen
Tina Nguyen
ALAnthony Lau
Anthony Lau
JBJulia Bier
Julia Bier
KCKristen C. Cooke
Kristen C. Cooke
HLHelen Lenthall
Helen Lenthall
EDElissa K. Deenick
Elissa K. Deenick
Heterozygous loss-of-function (LOF) mutations in PIK3R1 (encoding phosphatidylinositol 3-kinase [PI3K] regulatory subunits) cause activated PI3Kδ syndrome 2 (APDS2), which has a similar clinical profile to APDS1, caused by heterozygous gain-of-function (GOF) mutations in PIK3CD (encoding the PI3K p110δ catalytic subunit). While several studies have established how PIK3CD GOF leads to immune dysregulation, less is known about how PIK3R1 LOF mutations alter cellular function. By studying a novel CRISPR/Cas9 mouse model and patients’ immune cells, we determined how PIK3R1 LOF alters cellular function. We observed some overlap in cellular defects in APDS1 and APDS2, including decreased intrinsic B cell class switching and defective Tfh cell function. However, we also identified unique APDS2 phenotypes including defective expansion and affinity maturation of Pik3r1 LOF B cells following immunization, and decreased survival of Pik3r1 LOF pups. Further, we observed clear differences in the way Pik3r1 LOF and Pik3cd GOF altered signaling. Together these results demonstrate crucial differences between these two genetic etiologies.